Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Inks $500M Subscription Agreement to Fund Life Tech Purchase

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it has entered into a subscription agreement to raise $500 million in gross proceeds to help fund its purchase of Life Technologies.

Under the terms of the agreement, which Thermo Fisher disclosed in a document filed with the US Securities and Exchange Commission, the company will issue in a private placement up to approximately 5.3 million shares of its common stock to Temasek at $95 per share. The share price will be adjusted depending on when the investment closes.

Temasek is a government-owned investment firm based in Singapore.

Thermo Fisher said it does not expect to sell any more equity or equity-linked securities to fund the $13.6 billion acquisition of Life Tech, expected to be completed in early 2014. It previously raised $2.2 billion in a public offering of its shares and entered into a bridge credit agreement and term loan agreement totaling $12.5 billion in order to finance the deal.

In Friday morning trade on the New York Stock Exchange, shares of Thermo Fisher were up 1 percent at $101.18.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.